Why InTest’s latest earnings matter for investors

InTest (INTT) is back in focus after first quarter results showed sales of US$33.89 million and net income of US$0.789 million, alongside new second quarter guidance and a higher full year revenue outlook.

The earnings beat and raised guidance have come alongside strong momentum in the stock, with a 90 day share price return of 80% and a 1 year total shareholder return of 212.4%, even though the 3 year total shareholder return is slightly negative.

If the recent move in InTest has you considering where else growth stories could emerge, it may be worth scanning 41 AI infrastructure stocks

With InTest now profitable again, a higher full year revenue outlook, and the stock trading close to its analyst price target, investors may ask whether there is still value on the table or if the market is already pricing in future growth.

Most Popular Narrative: 7% Overvalued

Analysts following InTest currently see fair value at about $17.67 per share, which sits below the last close of $18.90, and that gap is driven by specific growth and margin assumptions rather than short term trading moves.

Diversification beyond semiconductors into defense, automotive/EV, life sciences, and safety/security markets is yielding increasing orders and reduced cyclicality, enhancing revenue resilience and opening new, higher-margin growth vectors.

Want to see what kind of revenue mix and margin profile has to show up for that fair value to stack up? The narrative leans on stronger earnings growth, firmer profitability, and a richer future earnings multiple than the stock has carried before, all tied together using a single discount rate that keeps every assumption on a tight leash.

Result: Fair Value of $17.67 (OVERVALUED)

However, the narrative still hinges on a recovery in weaker semiconductor and automotive markets, as well as on smooth execution at the new Malaysia facility, where delays or underutilization could pressure growth and margins.

Another view: what the sales multiple is saying

The narrative-based fair value of $17.67 suggests InTest is about 7% overvalued, yet the stock trades on a P/S of 1.9x, compared with 2.7x for its fair ratio, 2.6x for peers and 8.9x for the wider US Semiconductor group. That gap points to valuation risk on the growth story, but also potential upside if sentiment shifts closer to those benchmarks. Which side of that trade-off do you think matters more for your own thesis?

Next Steps

With the stock’s strong run and mixed signals on valuation, sentiment is clearly divided, so now is a good time to look at the numbers yourself and decide what really matters. To weigh the upside against the concerns in one place, review the 3 key rewards and 2 important warning signs

Looking for more investment ideas?

If InTest is on your radar, this is a good time to widen your search and line up a few more stocks that might fit your goals.

• Target quality at a discount by scanning 47 high quality undervalued stocks. These combine solid fundamentals with prices that may not fully reflect their underlying strength.
• Prioritise resilience and sleep-better-at-night holdings by reviewing the 67 resilient stocks with low risk scores, which score well on stability and downside protection.
• Expand your watchlist with under-the-radar businesses using the screener containing 22 high quality undiscovered gems before attention and liquidity potentially move elsewhere.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.